Experience in Treating Atherosclerosis Based on Professor Guo Shuwen’s Theory of “Qi Deficiency and Turbid Stasis”
Download PDF

Keywords

Atherosclerosis
Guo Shuwen
Experience of renowned veteran Chinese medicine practitioners
Qi deficiency and turbid stasis

DOI

10.26689/jcnr.v10i4.14826

Submitted : 2026-04-20
Accepted : 2026-05-05
Published : 2026-05-20

Abstract

Atherosclerosis is the pathological basis leading to various chronic internal diseases, such as peripheral atherosclerosis, coronary heart disease, cerebral infarction, etc. Professor Guo Shuwen, based on the pathophysiological characteristics of atherosclerosis and plaque formation, believes that the gradual decline in physical function and metabolic function in middle-aged and elderly people leads to the formation of pathological products, which in turn cause the occurrence and development of diseases. Therefore, clinical practice emphasizes the key pathological links of “gradual deficiency” or “intrinsic deficiency”. Qi deficiency is the root cause of the formation of pathological products such as turbidity, phlegm, blood stasis, and toxicity. That is, Qi deficiency does not circulate, turbid phlegm is diffuse, and blood stasis is the main pathological characteristics. The theory of “Qi deficiency, turbidity, and blood stasis” is proposed to treat atherosclerosis. Clinically, the method of nourishing Qi to resolve turbidity and promoting blood circulation to clear the meridians is applied, and the therapeutic effect is satisfactory.

References

Ge J, Wang C, Wang J, 2024, Internal Medicine (10th Edition). Beijing: People’s Medical Publishing House: 232–257.

Zeng G, Chen Y, Li B, et al., 2010, Effects of Astragalus Polysaccharides on Endothelial Cell Function in Rabbit Atherosclerosis. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Diseases, 8(10): 1206–1208.

Lin H, Charles A, Hsieh C, et al., 2015, Antioxidant Effects of 14 Chinese Traditional Medicinal Herbs Against Human Low-Density Lipoprotein Oxidation. Journal of Traditional and Complementary Medicine, 5(1): 51–55.

Zhang J, Yin R, Chen Q, et al., Exploring the Potential Mechanism of Danggui Buxue Decoction in Treating Atherosclerosis Based on Network Pharmacology and Molecular Docking. World Science and Technology-Modernization of Traditional Chinese Medicine, 23(4): 1076–1083.

Wu J, Wu J, Sui S, et al., 2015, Regulatory Effects of Earthworm Freeze-dried Powder on Cholesterol Reverse Transport-related Genes in Hyperlipidemic Mice. Journal of Hebei University (Natural Science Edition), 35(2): 159–164.

Zhao W, Zhang N, Zhou H, et al., 2016, Effects of Total Flavonoids From Panax Notoginseng on Blood Lipids in Hyperlipidemic Rats. Chinese Journal of Experimental Traditional Medical Formulae, 2016(8): 143–147.

Kuang R, Chen N, Kang H, et al., 2013, Mechanism Study on the Effects of Total Flavonoids from Hawthorn Leaves on Atherosclerosis in Rabbits. Chinese Journal of Modern Applied Pharmacy, 30(4): 372.

Zhang C, Wang D, Xi B, et al., 2013, Protective Effects of Alismatis Rhizoma on Vascular Endothelial Cell Injury Induced by ox-LDL. Lishizhen Medicine and Materia Medica Research, 24(4): 796–798.

Lee Y, Chuah A, Yamaguchi T, et al., 2008, Antioxidant Activity of Traditional Chinese Medicinal Herbal Materials. Food Sci Technol Res, 4(4): 205–210.

Zhang L, Sun Q, Guo S, et al., 2014, Effects of Lipid-regulating and Meridian-unblocking Traditional Chinese Medicine on the Expression of Inflammatory Factors in a Rabbit Model of Atherosclerosis. Journal of Beijing University of Traditional Chinese Medicine, 37(3): 171–174 + 189 + 3.

Su Z, Guo S, Zhang L, et al., 2017, Effects of the Lipid-regulating and Meridian-unblocking Formula on Vascular Remodeling in a Rabbit Model of Atherosclerosis. Global Traditional Chinese Medicine, 10(4): 430–435.

Zhang L, Sun Q, Guo S, et al., 2018, Effects of Lipid-regulating and Meridian-unblocking Traditional Chinese Medicine on Endothelial Cell Markers in a Rabbit Model of Atherosclerosis. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Diseases, 27(10): 1777–1780.